Showing results (1331-1340 of 1,861) with videos related to

Sort By:
Pageof 187
Gut|November 26, 2018
Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancerOlabisi Oluwabukola Coker, Geicho Nakatsu, Rudin Zhenwei Dai, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 21, 1994
Gene therapy of murine teratocarcinoma: separate functions for insulin-like growth factors I and II in immunogenicity and differentiationJ Trojan, T R Johnson, S D Rudin, et al.
Antimicrobial Agents and Chemotherapy|November 12, 2014
Genomic and transcriptomic analyses of colistin-resistant clinical isolates of Klebsiella pneumoniae reveal multiple pathways of resistanceMeredith S Wright, Yo Suzuki, Marcus B Jones, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 12, 2018
Chemotherapy sensitization of glioblastoma by focused ultrasound-mediated delivery of therapeutic liposomesAlexandros Papachristodoulou, Rea Deborah Signorell, Beat Werner, et al.
Frontiers in Immunology|November 13, 2023
Severe chronic non-bacterial osteomyelitis in combination with total MPO deficiency and responsiveness to TNFα inhibitionMartina Sundqvist, Karin Christenson, Per Wekell, et al.
RSC Medicinal Chemistry|August 6, 2021
Illuminating the norepinephrine transporter: fluorescent probes based on nisoxetine and talopramGisela Andrea Camacho-Hernandez, Andrea Casiraghi, Deborah Rudin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2004
A phase II study of oxaliplatin and paclitaxel in patients with advanced non-small-cell lung cancerJ D Winegarden, A M Mauer, G A Otterson, et al.
Antimicrobial Agents and Chemotherapy|February 21, 2019
Apotransferrin in Combination with Ciprofloxacin Slows Bacterial Replication, Prevents Resistance Amplification, and Increases Antimicrobial Regimen EffectPaul G Ambrose, Brian D VanScoy, Brian M Luna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2004
Delivery of a liposomal c-raf-1 antisense oligonucleotide by weekly bolus dosing in patients with advanced solid tumors: a phase I studyCharles M Rudin, John L Marshall, Chao Hui Huang, et al.
Pageof 187